Clinical trial with glipizide in uncomplicated maturity onset diabetes mellitus

A clinical trial with a new hypoglycaemic drug glipizide was carried out for an average period of 7 months, on 51 non-insulin independent adult diabetics attending the out-patients clinic of the Diabetic Association of Pakistan, Karachi. Forty five patients were satisfactorily controlled on glipizide. No toxic side effects were observed and the drug was well tolerated.